OK Biotech Co., Ltd.

TWSE:4155 Voorraadrapport

Marktkapitalisatie: NT$3.6b

De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

OK Biotech Balans Gezondheid

Financiële gezondheid criteriumcontroles 6/6

OK Biotech heeft een totaal eigen vermogen van NT$2.5B en een totale schuld van NT$420.2M, wat de schuld-eigenvermogensverhouding op 17% brengt. De totale activa en totale passiva bedragen respectievelijk NT$3.6B en NT$1.1B. De EBIT OK Biotech is NT$8.1M waardoor de rentedekking 24 is. Het heeft contanten en kortetermijnbeleggingen van NT$404.9M.

Belangrijke informatie

17.0%

Verhouding schuld/eigen vermogen

NT$420.16m

Schuld

Rente dekkingsratio24x
ContantNT$404.87m
AandelenNT$2.47b
Totaal verplichtingenNT$1.08b
Totaal activaNT$3.55b

Recente financiële gezondheidsupdates

OK Biotech (TPE:4155) Has A Pretty Healthy Balance Sheet

Mar 17
OK Biotech (TPE:4155) Has A Pretty Healthy Balance Sheet

Here's Why OK Biotech (TPE:4155) Can Manage Its Debt Responsibly

Dec 08
Here's Why OK Biotech (TPE:4155) Can Manage Its Debt Responsibly

Recent updates

OK Biotech's (TWSE:4155) Shareholders Have More To Worry About Than Lackluster Earnings

Aug 20
OK Biotech's (TWSE:4155) Shareholders Have More To Worry About Than Lackluster Earnings

OK Biotech Co., Ltd. (TPE:4155) Investors Should Think About This Before Buying It For Its Dividend

Apr 26
OK Biotech Co., Ltd. (TPE:4155) Investors Should Think About This Before Buying It For Its Dividend

Calculating The Fair Value Of OK Biotech Co., Ltd. (TPE:4155)

Apr 04
Calculating The Fair Value Of OK Biotech Co., Ltd. (TPE:4155)

OK Biotech (TPE:4155) Has A Pretty Healthy Balance Sheet

Mar 17
OK Biotech (TPE:4155) Has A Pretty Healthy Balance Sheet

Has OK Biotech (TPE:4155) Got What It Takes To Become A Multi-Bagger?

Mar 01
Has OK Biotech (TPE:4155) Got What It Takes To Become A Multi-Bagger?

Is OK Biotech Co., Ltd.'s (TPE:4155) Recent Price Movement Underpinned By Its Weak Fundamentals?

Feb 15
Is OK Biotech Co., Ltd.'s (TPE:4155) Recent Price Movement Underpinned By Its Weak Fundamentals?

A Look At OK Biotech's (TPE:4155) Share Price Returns

Jan 31
A Look At OK Biotech's (TPE:4155) Share Price Returns

We Wouldn't Rely On OK Biotech's (TPE:4155) Statutory Earnings As A Guide

Jan 17
We Wouldn't Rely On OK Biotech's (TPE:4155) Statutory Earnings As A Guide

Consider This Before Buying OK Biotech Co., Ltd. (TPE:4155) For The 5.4% Dividend

Jan 03
Consider This Before Buying OK Biotech Co., Ltd. (TPE:4155) For The 5.4% Dividend

Estimating The Intrinsic Value Of OK Biotech Co., Ltd. (TPE:4155)

Dec 21
Estimating The Intrinsic Value Of OK Biotech Co., Ltd. (TPE:4155)

Here's Why OK Biotech (TPE:4155) Can Manage Its Debt Responsibly

Dec 08
Here's Why OK Biotech (TPE:4155) Can Manage Its Debt Responsibly

Should You Be Impressed By OK Biotech's (TPE:4155) Returns on Capital?

Nov 23
Should You Be Impressed By OK Biotech's (TPE:4155) Returns on Capital?

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( NT$1.5B ) 4155 } overtreffen de korte termijn passiva ( NT$866.1M ).

Langlopende schulden: De kortetermijnactiva 4155 ( NT$1.5B ) overtreffen de langetermijnschulden ( NT$213.0M ).

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: De netto schuld/eigen vermogen ratio ( 0.6% ) 4155 wordt als voldoende beschouwd.

Schuld verminderen: De schuld/eigen vermogen-ratio van 4155 is de afgelopen 5 jaar gedaald van 23.2% naar 17%.

Schuldendekking: De schuld van 4155 wordt goed gedekt door de operationele kasstroom ( 42.6% ).

Rentedekking: De rentebetalingen op de schuld van 4155 worden goed gedekt door EBIT ( 24 x dekking).

Balans

Ontdek gezonde bedrijven

7D

1Y

7D

1Y

7D

1Y